- Home
- LOCO vs RGNX Comparison
LOCO vs RGNX Comparison
Compare LOCO & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOCO | RGNX |
|---|---|---|
| Founded | 1980 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.5M | 487.2M |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LOCO | RGNX |
|---|---|---|
| Price | $14.97 | $7.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | $20.75 | ★ $21.40 |
| AVG Volume (30 Days) | 306.5K | ★ 1.2M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.65 | ★ 18.08 |
| EPS | ★ 0.93 | N/A |
| Revenue | ★ $401,701,000.00 | $10,393,000.00 |
| Revenue This Year | $2.70 | N/A |
| Revenue Next Year | $4.35 | $59.15 |
| P/E Ratio | $15.89 | ★ N/A |
| Revenue Growth | 5.68 | ★ 126.48 |
| 52 Week Low | $9.99 | $5.46 |
| 52 Week High | $17.40 | $16.19 |
Technical Indicators
Market Signals| Indicator | LOCO | RGNX |
|---|---|---|
| Relative Strength Index (RSI) | 47.29 | 50.75 |
| Support Level | $14.23 | $6.79 |
| Resistance Level | $15.76 | $8.31 |
| Average True Range (ATR) | 0.63 | 0.60 |
| MACD | -0.08 | 0.12 |
| Stochastic Oscillator | 39.54 | 50.65 |
Price Performance
Historical ComparisonAbout LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.